Filing Details
- Accession Number:
- 0001209191-23-025294
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-21 21:05:47
- Reporting Period:
- 2023-04-20
- Accepted Time:
- 2023-04-21 21:05:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649989 | Outlook Therapeutics Inc. | OTLK | Biological Products, (No Disgnostic Substances) (2836) | 383982704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760510 | Terry Dagnon | C/O Outlook Therapeutics, Inc. 485 Route 1 South, Building F, Suite 320 Iselin NJ 08830 | Chief Operations Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-04-20 | 520,000 | $1.14 | 653,058 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.
Billionaire Hedge Funds
